Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
LOSARTAN ARENA 25 mg
Angiotensin II receptor antagonist, indicated in the treatment of arterial hypertension
Active Substance (INN)
LOSARTANUM POTASSIUM
Packaging
3, 5 blisters x 10 FCT
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.